GlassScriptPhysician profile
Jagmohan S Batra
NPI 1801936844
$5,051.58
in general payments reported to CMS, 2019-2025
14 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Pediatric Infectious Diseases provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $521 · 2021: $475 · 2022: $1,998 · 2023: $509 · 2024: $692 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,532.20 | 2019-2025 | Sunlenca |
| Partner Therapeutics, INC. | $1,356.88 | 2022 | |
| Janssen Biotech, INC. | $735.48 | 2019-2023 | Symtuza |
| Viiv Healthcare Company | $560.20 | 2019-2025 | Dovato, Cabenuva |
| Merck Sharp & Dohme LLC | $264.64 | 2019-2025 | Pifeltro, Delstrigo |
| Janssen Products, LP | $109.98 | 2019-2022 | |
| Insmed, INC. | $109.84 | 2020-2023 | Arikayce |
| Emd Serono, INC. | $90.83 | 2019-2025 | |
| Allergan, INC. | $72.07 | 2019-2020 | |
| Cook Medical LLC | $61.06 | 2022 | |
| Janssen Scientific Affairs, LLC | $55.70 | 2020-2021 | |
| Pfizer INC. | $47.41 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Sanofi Pasteur INC. | $26.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagmohan Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.